Approximately half of all breast cancers exhibited low expression of both PIPP and PTEN (83/174 tumors), with 21% (37/174) showing comparable expression of both PI-phosphatases relative to normal breast tissue (Supplementary Fig S6B). This evidence concerns the gene INPP5J and breast carcinoma.